These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 3862110)

  • 1. Predominance of hemodynamic rather than metabolic factors in the pathogenesis of diabetic glomerulopathy.
    Zatz R; Meyer TW; Rennke HG; Brenner BM
    Proc Natl Acad Sci U S A; 1985 Sep; 82(17):5963-7. PubMed ID: 3862110
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intrarenal Mechanisms of Sodium-Glucose Cotransporter-2 Inhibitors on Tubuloglomerular Feedback and Natriuresis.
    Koh ES; Kim GH; Chung S
    Endocrinol Metab (Seoul); 2023 Aug; 38(4):359-372. PubMed ID: 37482684
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of hypoxia-inducible factors in the pathogenesis of kidney diseases: a link through cell metabolism.
    Foresto-Neto O; da Silva ARPA; Cipelli M; Santana-Novelli FPR; Camara NOS
    Kidney Res Clin Pract; 2023 Sep; 42(5):561-578. PubMed ID: 37448286
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urine Immunoglobin G Greater Than 2.45 mg/L Has a Correlation with the Onset and Progression of Diabetic Kidney Disease: A Retrospective Cohort Study.
    Meng C; Chen J; Sun X; Guan S; Zhu H; Qin Y; Wang J; Li Y; Yang J; Chang B
    J Pers Med; 2023 Feb; 13(3):. PubMed ID: 36983632
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human Alpha-1 Antitrypsin Attenuates ENaC and MARCKS and Lowers Blood Pressure in Hypertensive Diabetic db/db Mice.
    Lugo CI; Liu LP; Bala N; Morales AG; Gholam MF; Abchee JC; Elmoujahid N; Elshikha AS; Avdiaj R; Searcy LA; Denslow ND; Song S; Alli AA
    Biomolecules; 2022 Dec; 13(1):. PubMed ID: 36671451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of allopurinol on cardiovascular outcomes in patients with type 2 diabetes: a systematic review.
    Bletsa E; Paschou SA; Tsigkou V; Stampouloglou PK; Vasileiou V; Kassi GN; Oikonomou E; Siasos G
    Hormones (Athens); 2022 Dec; 21(4):599-610. PubMed ID: 36197637
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glomerular hyperfiltration.
    Cortinovis M; Perico N; Ruggenenti P; Remuzzi A; Remuzzi G
    Nat Rev Nephrol; 2022 Jul; 18(7):435-451. PubMed ID: 35365815
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dietary protein sources and risk of diabetic nephropathy in women: A case-control study.
    Aziz M; Jalilpiran Y; Nekouimehr M; Fattahi S; Mokhtari P; Jayedi A; Yekaninejad MS; Mirzaei K
    BMC Endocr Disord; 2021 Aug; 21(1):174. PubMed ID: 34452618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SGLT2 inhibitors, hemodynamics, and kidney protection.
    Ellison DH
    Am J Physiol Renal Physiol; 2021 Jul; 321(1):F47-F49. PubMed ID: 33749325
    [No Abstract]   [Full Text] [Related]  

  • 10. Effects of SGLT2 inhibitor and dietary NaCl on glomerular hemodynamics assessed by micropuncture in diabetic rats.
    Thomson SC; Vallon V
    Am J Physiol Renal Physiol; 2021 May; 320(5):F761-F771. PubMed ID: 33645318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SGLT2 Inhibitors and Kidney Outcomes in Patients with Chronic Kidney Disease.
    Kanduri SR; Kovvuru K; Hansrivijit P; Thongprayoon C; Vallabhajosyula S; Pivovarova AI; Chewcharat A; Garla V; Medaura J; Cheungpasitporn W
    J Clin Med; 2020 Aug; 9(9):. PubMed ID: 32846935
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of Uric Acid on Diabetes Mellitus and Its Chronic Complications.
    Xiong Q; Liu J; Xu Y
    Int J Endocrinol; 2019; 2019():9691345. PubMed ID: 31737070
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The New Biology of Diabetic Kidney Disease-Mechanisms and Therapeutic Implications.
    Lytvyn Y; Bjornstad P; van Raalte DH; Heerspink HL; Cherney DZI
    Endocr Rev; 2020 Apr; 41(2):202-31. PubMed ID: 31633153
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antihyperglycemic agents as novel natriuretic therapies in diabetic kidney disease.
    León Jiménez D; Cherney DZI; Bjornstad P; Castilla-Guerra L; Miramontes González JP
    Am J Physiol Renal Physiol; 2018 Nov; 315(5):F1406-F1415. PubMed ID: 30066584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Developing Treatments for Chronic Kidney Disease in the 21st Century.
    Breyer MD; Susztak K
    Semin Nephrol; 2016 Nov; 36(6):436-447. PubMed ID: 27987541
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renal disease pathophysiology and treatment: contributions from the rat.
    Mullins LJ; Conway BR; Menzies RI; Denby L; Mullins JJ
    Dis Model Mech; 2016 Dec; 9(12):1419-1433. PubMed ID: 27935823
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of Acute High Glucose on Protein Abundance Changes in Murine Glomerular Mesangial Cells.
    Barati MT; Gould JC; Salyer SA; Isaacs S; Wilkey DW; Merchant ML
    J Diabetes Res; 2016; 2016():3537863. PubMed ID: 26839892
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An Update on the Use of Animal Models in Diabetic Nephropathy Research.
    Betz B; Conway BR
    Curr Diab Rep; 2016 Feb; 16(2):18. PubMed ID: 26814757
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of Low-Protein Diets Supplemented with Ketoacid on Expression of TGF-β and Its Receptors in Diabetic Rats.
    Yang X; Yang M; Cheng M; Ma LB; Xie XC; Han S; Zhang B; Fei X; Wang M; Mei CL
    Biomed Res Int; 2015; 2015():873519. PubMed ID: 26788514
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential urinary glycoproteome analysis of type 2 diabetic nephropathy using 2D-LC-MS/MS and iTRAQ quantification.
    Guo Z; Liu X; Li M; Shao C; Tao J; Sun W; Li M
    J Transl Med; 2015 Nov; 13():371. PubMed ID: 26608305
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.